Computational and combinatorial chemistry-based approach to farnesyltransferase inhibitors.

被引：0
|
作者：
Park, JG
Kollmeyer, TM
Xu, K
Prendergast, FG
Pang, YP
机构：
[1] Mayo Fdn Med Educ & Res, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[2] Mayo Fdn Med Educ & Res, Tumor Biol Program, Rochester, MN 55905 USA
[3] Mayo Fdn Med Educ & Res, Mayo Clin Canc Ctr, Rochester, MN 55905 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
153-MEDI
引用
收藏
页码：U27 / U27
页数：1
相关论文
共 50 条
  • [1] Protein farnesyltransferase inhibitors.
    Graham, SL
    Anthony, NJ
    Conner, MW
    deSolms, SJ
    Gibbs, JB
    Hartman, GD
    Koblan, KS
    Kohl, NE
    Oliff, A
    Omer, CA
    Williams, TM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U889 - U889
  • [2] Evolving therapies: farnesyltransferase inhibitors.
    Purcell W.T.
    Donehower R.C.
    Current Oncology Reports, 2002, 4 (1) : 29 - 36
  • [3] A computational chemistry-based approach to optimizing PD-1/PD-L1 inhibitors
    Zhai, Meijuan
    Ji, Shiliang
    Hu, Haoran
    Wu, Yongjie
    Shi, Yi
    Zhu, Ruifang
    Jiang, Yiguo
    Yang, Yang
    FRONTIERS IN CHEMISTRY, 2025, 12
  • [4] Thiazolidinediones as novel farnesyltransferase inhibitors.
    Ayral-Kaloustian, S
    Birnberg, GH
    Cheung, K
    Epstein, JW
    MacEwan, G
    Salaski, E
    Hollander, I
    Kim, SC
    Chen, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U653 - U653
  • [5] Chemistry-based design of inhibitors for carboxypeptidase A
    Kim, DH
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (12) : 1217 - 1226
  • [6] Design and synthesis of pyridone farnesyltransferase inhibitors.
    Hasvold, LA
    Wang, WB
    Rockway, TW
    Gwaltney, SL
    Nelson, LTJ
    Mantei, R
    Fakhoury, S
    Sullivan, G
    Wang, L
    Lin, NH
    Li, Q
    Cohen, J
    Gu, WZ
    Zhang, HY
    Marsh, K
    Bauch, J
    Gintant, G
    McDermott, J
    Salmen, H
    Rosenberg, S
    Sham, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U28 - U28
  • [7] Synthesis and evaluation of novel pyrrolidinone-based farnesyltransferase inhibitors.
    Gallicchio, SN
    Beese, LS
    Bell, IM
    Beshore, DC
    Buser-Doepner, C
    Gibbs, JB
    Graham, SL
    Hartman, GD
    Heimbrook, DC
    Kassahun, K
    Koblan, KS
    Kohl, NE
    Lobell, RB
    Rodrigues, DA
    Taylor, JS
    Williams, TM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U28 - U28
  • [8] A Novel Proteomic Approach to Define Leukemia Cell Resistance to Farnesyltransferase Inhibitors.
    Onono, Fredrick O.
    Morgan, Michael A.
    Spielmann, H. Peter
    Andres, Douglas A.
    Scherr, Michaela
    Venturini, Letizia
    Dallman, Iris
    Ganser, Arnold
    Reuter, Christoph W. M.
    BLOOD, 2009, 114 (22) : 1448 - 1448
  • [9] Combination of structure-based design and combinatorial chemistry for the development of cathepsin D inhibitors.
    Kick, EK
    Roe, DC
    Skillman, AD
    Liu, GC
    Ewing, TJA
    Sun, YX
    Kuntz, ID
    Ellman, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 67 - ORGN
  • [10] Discovery and SAR of tetrahydrobenzodiazepine class of farnesyltransferase inhibitors.
    Ding, CZ
    Miller, AV
    Bhide, R
    Cho, Y
    Guo, P
    Kim, SH
    Leftheris, K
    Mitt, T
    Patel, M
    Robert, S
    Vite, G
    Ricca, C
    Yan, N
    Stealey, B
    Manne, V
    Hunt, JT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U130 - U130
12345